Caveolin-1 Expression Predicts Efficacy of Weekly Nab-Paclitaxel Plus Gemcitabine for Metastatic Breast Cancer in the Phase II Clinical Trial
BMC Cancer - United Kingdom
doi 10.1186/s12885-018-4936-y
Full Text
Open PDFAbstract
Available in full text
Date
October 22, 2018
Authors
Publisher
Springer Science and Business Media LLC